Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Anti-apoptotic proteins and catalase-dependent apoptosis resistance in nickel chloride-transformed human lung epithelial cells.

Yang YX, Li XL, Wang L, Han SY, Zhang YR, Pratheeshkumar P, Wang X, Lu J, Yin YQ, Sun LJ, Budhraja A, Hitron AJ, Ding SZ.

Int J Oncol. 2013 Sep;43(3):936-46. doi: 10.3892/ijo.2013.2004. Epub 2013 Jul 3.

2.

Quercitrin protects skin from UVB-induced oxidative damage.

Yin Y, Li W, Son YO, Sun L, Lu J, Kim D, Wang X, Yao H, Wang L, Pratheeshkumar P, Hitron AJ, Luo J, Gao N, Shi X, Zhang Z.

Toxicol Appl Pharmacol. 2013 Jun 1;269(2):89-99. doi: 10.1016/j.taap.2013.03.015. Epub 2013 Mar 29.

3.

Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.

Ding SZ, Yang YX, Li XL, Michelli-Rivera A, Han SY, Wang L, Pratheeshkumar P, Wang X, Lu J, Yin YQ, Budhraja A, Hitron AJ.

Toxicol Appl Pharmacol. 2013 May 15;269(1):61-71. doi: 10.1016/j.taap.2013.03.006. Epub 2013 Mar 19.

4.

Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.

Pratheeshkumar P, Son YO, Budhraja A, Wang X, Ding S, Wang L, Hitron A, Lee JC, Kim D, Divya SP, Chen G, Zhang Z, Luo J, Shi X.

PLoS One. 2012;7(12):e52279. doi: 10.1371/journal.pone.0052279. Epub 2012 Dec 31.

5.

Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.

Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, Wang L, Hitron A, Lee JC, Xu M, Chen G, Luo J, Shi X.

PLoS One. 2012;7(10):e47516. doi: 10.1371/journal.pone.0047516. Epub 2012 Oct 18.

6.

Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Pratheeshkumar P, Sreekala C, Zhang Z, Budhraja A, Ding S, Son YO, Wang X, Hitron A, Hyun-Jung K, Wang L, Lee JC, Shi X.

Anticancer Agents Med Chem. 2012 Dec;12(10):1159-84. Review.

7.

The influence of antidiabetic medications on the development and progression of prostate cancer.

Hitron A, Adams V, Talbert J, Steinke D.

Cancer Epidemiol. 2012 Aug;36(4):e243-50. doi: 10.1016/j.canep.2012.02.005. Epub 2012 Mar 13. Review.

8.

Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo.

Budhraja A, Gao N, Zhang Z, Son YO, Cheng S, Wang X, Ding S, Hitron A, Chen G, Luo J, Shi X.

Mol Cancer Ther. 2012 Jan;11(1):132-42. doi: 10.1158/1535-7163.MCT-11-0343. Epub 2011 Nov 14.

9.

Accuracy of empiric gentamicin dosing guidelines in neonates.

Hitron AE, Sun Y, Scarpace SB.

J Pediatr Pharmacol Ther. 2010 Oct;15(4):264-73.

10.

Incidence and risk factors of clinically significant chemotherapy-induced thrombocytopenia in patients with solid tumors.

Hitron A, Steinke D, Sutphin S, Lawson A, Talbert J, Adams V.

J Oncol Pharm Pract. 2011 Dec;17(4):312-9. doi: 10.1177/1078155210380293. Epub 2010 Sep 7.

PMID:
20823048
11.

Arsenic promotes angiogenesis in vitro via a heme oxygenase-1-dependent mechanism.

Meng D, Wang X, Chang Q, Hitron A, Zhang Z, Xu M, Chen G, Luo J, Jiang B, Fang J, Shi X.

Toxicol Appl Pharmacol. 2010 May 1;244(3):291-9. doi: 10.1016/j.taap.2010.01.004. Epub 2010 Jan 18.

PMID:
20083128
12.

The pharmacological management of skeletal-related events from metastatic tumors.

Hitron A, Adams V.

Orthopedics. 2009 Mar;32(3):188.

PMID:
19309055

Supplemental Content

Loading ...
Support Center